(Q61939408)
Statements
COMPOSE 1 (English)
0 references
A Placebo Controlled, Randomized, Double-Blind, Fixed-dose, Multicenter, Phase IIb Study to Investigate the Efficacy and Tolerability of BAY58-2667 (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF) (English)
0 references
March 2010
0 references
January 2011
0 references
12
0 references
18 year
0 references